Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Karsten Geletneky, Jacek Hajda, Assia L. Angelova, +24

Molecular Therapy

Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

Assia L. Angelova, Marc Aprahamian, Svitlana P. Grekova, +8

Clinical Cancer Research

Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer

Assia L. Angelova, Svitlana P. Grekova, Anette Heller, +12

Journal of Virology

Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies

Assia L. Angelova, Marc Aprahamian, Ginette Balboni, +9

Molecular Therapy

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Jacek Hajda, Monika Lehmann, Ottheinz Krebs, +16

BMC Cancer

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity

Assia L. Angelova, Milena Barf, Karsten Geletneky, +2

Viruses

ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy +15

Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Jacek Hajda, Barbara Leuchs, Assia L. Angelova, +19

Clinical Cancer Research

Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer

Svitlana P. Grekova, Marc Aprahamian, Laurent Daeffler, +8

Cancer Biology & Therapy

Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas

Anette Heller, Assia L. Angelova, Sonja Bauer, +13

Pancreas

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers

Assia L. Angelova, Mathias Witzens‐Harig, Angel S. Galabov, +1

Frontiers in Oncology

Cancer ManagementImmunologyPathologyImmunotherapyCancer-associated Virus +14